IRIS
CASTAGNA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.977
AS - Asia 14.173
NA - Nord America 9.927
SA - Sud America 3.658
AF - Africa 325
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 43.096
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.468
RU - Federazione Russa 8.852
SG - Singapore 5.054
CN - Cina 4.661
BR - Brasile 3.023
HK - Hong Kong 1.680
VN - Vietnam 1.469
SE - Svezia 1.442
IT - Italia 1.037
RO - Romania 778
FR - Francia 722
DE - Germania 721
GB - Regno Unito 384
IN - India 277
AR - Argentina 264
FI - Finlandia 255
CA - Canada 225
AT - Austria 171
MX - Messico 159
BD - Bangladesh 154
ID - Indonesia 135
PL - Polonia 135
IQ - Iraq 122
ZA - Sudafrica 116
NL - Olanda 105
EC - Ecuador 101
TR - Turchia 94
JP - Giappone 91
ES - Italia 84
CO - Colombia 77
IE - Irlanda 63
PK - Pakistan 59
LT - Lituania 53
UA - Ucraina 53
VE - Venezuela 51
PY - Paraguay 48
MA - Marocco 47
SA - Arabia Saudita 43
CL - Cile 42
PH - Filippine 39
UZ - Uzbekistan 39
EG - Egitto 37
TN - Tunisia 29
IR - Iran 25
AE - Emirati Arabi Uniti 24
MY - Malesia 24
BE - Belgio 21
IL - Israele 21
NP - Nepal 21
KE - Kenya 20
UY - Uruguay 20
DZ - Algeria 19
AU - Australia 18
DO - Repubblica Dominicana 18
PE - Perù 17
AZ - Azerbaigian 16
KZ - Kazakistan 15
OM - Oman 14
AL - Albania 13
JO - Giordania 12
SY - Repubblica araba siriana 12
EU - Europa 11
BO - Bolivia 10
CH - Svizzera 10
CI - Costa d'Avorio 10
KR - Corea 10
TH - Thailandia 10
JM - Giamaica 9
MD - Moldavia 9
CZ - Repubblica Ceca 8
ET - Etiopia 8
NG - Nigeria 8
RS - Serbia 8
HN - Honduras 7
HR - Croazia 7
KW - Kuwait 7
LB - Libano 7
LU - Lussemburgo 7
PA - Panama 7
BB - Barbados 6
GT - Guatemala 6
NI - Nicaragua 6
BH - Bahrain 5
GA - Gabon 5
NO - Norvegia 5
QA - Qatar 5
SI - Slovenia 5
SN - Senegal 5
AM - Armenia 4
BG - Bulgaria 4
BW - Botswana 4
DK - Danimarca 4
GE - Georgia 4
GY - Guiana 4
HU - Ungheria 4
KH - Cambogia 4
PS - Palestinian Territory 4
PT - Portogallo 4
SV - El Salvador 4
AO - Angola 3
Totale 43.037
Salva come PNG Salva come JPEG
Città #
Singapore 2.377
Dallas 2.226
Moscow 1.928
Hong Kong 1.668
Ashburn 1.271
San Jose 1.078
Shanghai 816
Hefei 685
Lauterbourg 589
Lawrence 542
Princeton 542
Ho Chi Minh City 513
Beijing 481
New York 448
Shenzhen 446
Milan 350
Hanoi 325
São Paulo 279
Los Angeles 265
Nuremberg 203
Munich 199
Helsinki 156
Orem 141
Boardman 126
Warsaw 114
Denver 110
Santa Clara 106
Rio de Janeiro 91
Rome 87
Tokyo 84
Chennai 83
Da Nang 81
Guangzhou 81
Montreal 80
London 77
Johannesburg 72
Poplar 70
Council Bluffs 69
Haiphong 67
Vienna 67
Brooklyn 66
Frankfurt am Main 65
Washington 65
Atlanta 62
Stockholm 61
Belo Horizonte 59
Curitiba 59
Houston 59
Amsterdam 58
Dublin 58
Turku 58
Manchester 56
Toronto 55
Brasília 54
Mexico City 53
Baghdad 52
Seattle 52
Chicago 48
Campinas 46
Porto Alegre 43
Biên Hòa 42
Phoenix 41
Quito 40
Cesano Boscone 39
Falkenstein 39
Lappeenranta 38
Tashkent 38
Pune 35
Ankara 34
Boston 33
Hải Dương 31
Guayaquil 30
The Dalles 30
Mumbai 29
Salvador 28
St Petersburg 28
Tianjin 28
Hangzhou 27
Jakarta 26
Querétaro 26
Barnet 25
Columbus 25
Istanbul 25
New Delhi 25
Thái Bình 25
Buenos Aires 24
Dhaka 24
Gatchina 24
Goiânia 24
Guarulhos 24
San Francisco 24
Sorocaba 23
Lahore 22
Turin 22
Can Tho 21
Asunción 20
Brescia 20
Ribeirão Preto 20
Bologna 19
Santo André 19
Totale 21.239
Salva come PNG Salva come JPEG
Nome #
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients 1.358
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 468
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 269
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment 249
Monkeypox in a patient with undifferentiated connective tissue disease 249
Viral bloodstream detection in mpox patients: An observational multicentric study 232
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 166
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 165
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 154
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
A follow-up study in asymptomatic HIV patients 145
Biobanking for COVID-19 research 144
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 142
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 142
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 140
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients 139
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 138
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 137
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 136
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 130
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 130
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 128
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics 127
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 125
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 124
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 122
Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy 120
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 117
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 117
HIV viral load monitoring during monkeypox virus infection among people with HIV 116
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 115
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 115
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 114
Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy 113
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 113
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 112
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 111
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 110
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure 109
A whole-genome association study of major determinants for host control of HIV-1 109
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients 109
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 109
Achieving virological control in pan-resistant HIV-1 infection: A case series 108
Risk of Cardiovascular Diseases or Mortality in People with Higher Values of HIV-1 DNA 108
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 108
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination 108
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 108
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 107
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 107
Subclinical myocardial dysfunction in patients recovered from COVID-19 107
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 106
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 106
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 106
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 106
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 105
High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy 104
Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy) 104
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach 103
Testosterone in males with COVID-19: A twelve-month cohort study 103
Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective 103
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort 103
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 103
Beyond stigma: Monkeypox infection in a 27-year-old woman 102
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial 102
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 102
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 102
Viral Hepatitis and Human Papillomavirus Vaccination during HIV Pre-Exposure Prophylaxis: Factors Associated with Missed Vaccination 101
Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience 101
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 101
Probable West Nile Virus hepatitis: Case report 100
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients 100
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients 100
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids 99
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 99
Isolated monkeypox proctitis among men who have sex with men 99
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient 99
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 99
Bictegravir 99
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 99
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia 99
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV 99
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 98
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults 97
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 97
Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report 96
Persistent ocular mpox infection in an immunocompetent individual 96
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study 96
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 96
A RELATIVELY SLOW RISK OF DISEASE PROGRESSION IN HIV-POSITIVE PATIENTS WITH INDOLENT INFECTION HAS BEEN FOUND IN THE ICONA COHORT 96
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia 94
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial 94
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir 94
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study 94
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 94
Prior Neisseria meningitidis (Nm) proctitis does not prevent Neisseria gonorrhoeae (Ng) proctitis among men who have sex with men (MSM) 93
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study 93
HIV-DNA undetectability during chronic HIV infection: Frequency and predictive factors 93
Severely low testosterone in males with COVID-19: a case-control study 93
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 91
Totale 13.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 259.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 259.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 7 4
2021/2022417 1 0 0 137 26 29 36 64 36 29 16 43
2022/20232.835 1.206 552 220 27 36 257 175 185 99 19 35 24
2023/20242.162 45 66 641 171 178 410 59 180 8 45 113 246
2024/20259.554 1.078 150 178 281 363 852 2.013 777 1.368 1.050 587 857
2025/202628.568 2.115 2.342 2.648 4.230 2.273 988 2.695 2.178 7.656 1.443 0 0
Totale 44.201